Similar articles

• Dose comparisons of clopidogrel and aspirin in acute coronary syndromes.

  CURRENT-OASIS 7 Investigators; Mehta SR, Bassand JP, Chrolavicius S, Diaz R, Eikelboom JW, Fox KA, Granger CB, Jolly S, Joyner CD, Rupprecht HJ, Widimsky P, Afzal R, Pogue J, Yusuf S. CURRENT-OASIS 7 Investigators, et al. N Engl J Med. 2010 Sep 2;363(10):930-42. doi: 10.1056/NEJMoa0909475. N Engl J Med. 2010. PMID: 20818903 Clinical Trial.
• [The CURRENT-OASIS 7 study].

  Ardissino D, Patti G, Magnani G, Mantovani F, Demola MA. Ardissino D, et al. G Ital Cardiol (Rome). 2011 Mar;12(3):167-71. G Ital Cardiol (Rome). 2011. PMID: 21560471 Italian. No abstract available.
• Aspirin combined with clopidogrel (Plavix) decreases cardiovascular events in patients with acute coronary syndrome.

  Walker CW, Dawley CA, Fletcher SF. Walker CW, et al. Am Fam Physician. 2007 Dec 1;76(11):1643-5. Am Fam Physician. 2007. PMID: 18092705 Review. No abstract available.
• Clinical outcomes according to permanent discontinuation of clopidogrel or placebo in the CHARISMA trial.

  Collet JP, Montalescot G, Steg PG, Steinhubl SR, Fox KA, Hu TF, Johnston SC, Hamm CW, Bhatt DL, Topol EJ. Collet JP, et al. Arch Cardiovasc Dis. 2009 Jun-Jul;102(6-7):485-96. doi: 10.1016/j.acvd.2009.03.012. Epub 2009 Jun 11. Arch Cardiovasc Dis. 2009. PMID: 19664568 Clinical Trial.
• Individualizing Duration of Dual Antiplatelet Therapy After Acute Coronary Syndrome or Percutaneous Coronary Intervention.

  Bagai A, Bhatt DL, Eikelboom JW, Mancini GB, Cohen EA, Vijayaraghavan R, Cheema AN, Udell JA, Niznick J, Tanguay JF, Verma S, Mehta SR. Bagai A, et al. Circulation. 2016 May 24;133(21):2094-8. doi: 10.1161/CIRCULATIONAHA.115.021158. Circulation. 2016. PMID: 27217435 Review. No abstract available.